focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOdyssean Inves. Regulatory News (OIT)

Share Price Information for Odyssean Inves. (OIT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 167.50
Bid: 167.50
Ask: 169.50
Change: 1.50 (0.90%)
Spread: 2.00 (1.194%)
Open: 167.50
High: 167.50
Low: 167.50
Prev. Close: 166.00
OIT Live PriceLast checked at -
Odyssean Investment Trust is an Investment Trust

To achieve attractive total returns per share principally through capital growth over a longterm period through investment in companies predominantly in the UK.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Benchmark Holdings Plc-Replacement

22 Jan 2024 17:14

RNS Number : 5170A
Odyssean Investment Trust PLC
22 January 2024
 

Amendment

An amendment has been made to section 2(a) of the Form 8 (DD) announcement released on 22 January 2024 at 13:48 under RNS No. 4976A.

All other details remain unchanged and the full amended announcement is as below.

 

 

FORM 8.3

 

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Odyssean Investment Trust PLC

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

Same as 1(a)

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Benchmark Holdings Plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

N/A

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

22 January 2024

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

No

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

0.1p ordinary share

 

 

Interests

Short positions

 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

21,015,000

2.84%

N/A

N/A

(2) Cash-settled derivatives:

 

N/A

N/A

N/A

N/A

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

N/A

N/A

N/A

N/A

TOTAL:

 

21,015,000

2.84%

N/A

N/A

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

N/A

N/A

N/A

N/A

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

N/A

N/A

N/A

N/A

N/A

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

N/A

N/A

N/A

N/A

N/A

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

N/A

N/A

N/A

N/A

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

No

 

 

Date of disclosure:

22 January 2024

Contact name:

Mark Pope, on behalf of Frostrow Capital LLP - Company Secretary

 

Telephone number*:

0203 008 4913

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETFLFLDLVIFFIS
Date   Source Headline
29th Mar 20232:03 pmRNSNet Asset Value(s)
28th Mar 20232:00 pmRNSHolding(s) in Company
28th Mar 20231:23 pmRNSNet Asset Value(s)
27th Mar 20231:11 pmRNSNet Asset Value(s)
24th Mar 202312:38 pmRNSNet Asset Value(s)
23rd Mar 20231:08 pmRNSNet Asset Value(s)
22nd Mar 20231:16 pmRNSNet Asset Value(s)
21st Mar 20234:27 pmRNSIssue of Equity
21st Mar 202312:56 pmRNSNet Asset Value(s)
20th Mar 20231:58 pmRNSNet Asset Value(s)
17th Mar 20231:04 pmRNSNet Asset Value(s)
16th Mar 20232:10 pmRNSForm 8.3 - Hyve Group plc
16th Mar 20231:58 pmRNSIssue of Equity
16th Mar 202311:58 amRNSNet Asset Value(s)
15th Mar 202312:51 pmRNSNet Asset Value(s)
14th Mar 20231:24 pmRNSNet Asset Value(s)
13th Mar 202312:43 pmRNSNet Asset Value(s)
10th Mar 20231:48 pmRNSNet Asset Value(s)
9th Mar 20232:11 pmRNSNet Asset Value(s)
9th Mar 202311:00 amRNSMonthly Fact Sheet as at 28 February 2023
8th Mar 20234:17 pmRNSHolding(s) in Company
8th Mar 20233:55 pmRNSNet Asset Value(s)
7th Mar 20231:14 pmRNSNet Asset Value(s)
6th Mar 20231:23 pmRNSNet Asset Value(s)
3rd Mar 20234:37 pmRNSHolding(s) in Company
3rd Mar 20231:28 pmRNSNet Asset Value(s)
2nd Mar 202312:45 pmRNSNet Asset Value(s)
1st Mar 20231:45 pmRNSNet Asset Value(s)
1st Mar 202310:54 amRNSTotal Voting Rights
1st Mar 20239:44 amRNSHolding(s) in Company
1st Mar 20237:00 amRNSDISCLOSURE UNDER RULE 2.10(C) OF THE TAKEOVER CODE
28th Feb 20231:55 pmRNSForm 8 (DD) -Curtis Bank Group PLC
28th Feb 20231:36 pmRNSNet Asset Value(s)
27th Feb 20233:32 pmRNSIssue of Equity
27th Feb 20232:48 pmRNSIssue of Equity
27th Feb 202312:29 pmRNSNet Asset Value(s)
24th Feb 20232:51 pmRNSNet Asset Value(s)
23rd Feb 20234:57 pmRNSIssue of Equity
23rd Feb 20231:48 pmRNSNet Asset Value(s)
23rd Feb 20238:36 amRNSDirectorate Change
22nd Feb 20235:18 pmRNSIssue of Equity
22nd Feb 20231:43 pmRNSNet Asset Value(s)
21st Feb 20234:01 pmRNSIssue of Equity
21st Feb 20232:37 pmRNSForm 8.3 - Hyve Group PLC
21st Feb 20232:06 pmRNSNet Asset Value(s)
20th Feb 20234:34 pmRNSIssue of Equity
20th Feb 20231:58 pmRNSNet Asset Value(s)
17th Feb 20234:57 pmRNSIssue of Equity
17th Feb 20231:10 pmRNSNet Asset Value(s)
17th Feb 202312:15 pmRNSForm 8.3 - Devro plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.